Results 1 to 10 of about 197,453 (230)

Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease

Journal of Clinical Medicine, 2022
Autosomal dominant polycystic kidney disease (ADPKD) has been associated with cardiac abnormalities including mitral valve prolapse and aneurysmal dilatation of the aortic root.
Jin Liu, K. Fujikura, Hreedi Dev, Sadjad Riyahi, J. Blumenfeld, Jiwon Kim, H. Rennert, M. Prince   +7 more
semanticscholar   +1 more source

Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy

Advances in Therapy, 2020
Introduction Cardiovascular toxicity of immunotherapy represents an underreported but potentially fatal side effect. A relatively high incidence of pericardial disease has been noticed in patients with non-small cell lung cancer (NSCLC).
M. Canale, A. Camerini, G. Casolo, A. Lilli, I. Bisceglia, I. Parrini, C. Lestuzzi, J. Del Meglio, C. Puccetti, L. Camerini, D. Amoroso, N. Maurea   +11 more
semanticscholar   +1 more source

Pericardial effusion in patients with COVID-19: case series

European Heart Journal: Case Reports, 2020
Background SARS-coronavirus-2 [coronavirus disease 2019 (COVID-19)] infection is a public health issue affecting millions of people. It started in Wuhan in China in December 2019 spreading rapidly worldwide.
F. Sauer, C. Dagrenat, P. Couppie, G. Jochum, P. Leddet   +4 more
semanticscholar   +1 more source

Symptomatic pericardial effusion in the setting of asymptomatic COVID-19 infection

Medicine, 2020
Rationale: Infection with the severe acute respiratory coronavirus disease 2019 (COVID-19) has been shown to cause multi-organ involvement including cardiopulmonary serosal layers infection and inflammation.
Behzad Amoozgar, Varun Kaushal, Umair Mubashar, Shuvendu Sen, Shakeel Yousaf, Matthew Yotsuya   +5 more
semanticscholar   +1 more source

Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer

Radiation Oncology, 2020
The literature regarding pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy (IMRT) for esophageal cancer was lacking.
T. Pao, Wei-Lun Chang, N. Chiang, Chia-Ying Lin, W. Lai, Y. Tseng, F. Lin   +6 more
semanticscholar   +1 more source

Etiology of Pericardial Effusion and Outcomes Post Pericardiocentesis in the Western Region of Saudi Arabia: A Single-center Experience

Cureus, 2020
Background Pericardial effusion is the accumulation of blood or excess fluid in the cavity between the heart and the pericardium sac. Pericardial effusion can be caused by several etiologies, including malignant and non-malignant causes ...
Saad Albugami, F. Al-Husayni, Abdullah Almalki, M. Dumyati, Ysear Zakri, J. Alrahimi   +5 more
semanticscholar   +1 more source

Chronic massive pericardial effusion: a case report and literature review

Journal of International Medical Research, 2020
Chronic massive pericardial effusion without cardiac tamponade is relatively rare. Nearly half of all patients with chronic large pericardial effusion are asymptomatic.
Ying-shuo Huang, Jianxiu Zhang, Ying-Xue Sun   +2 more
semanticscholar   +1 more source

Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis

Clinical Research in Cardiology, 2020
Pericardial and pleural effusion are common findings in patients with cardiac amyloidosis (CA). It is not known, whether effusions correlate with right ventricular (RV) function in these patients.
Christina Binder, F. Duca, T. Binder, R. Rettl, T. Dachs, B. Seirer, L. Camuz Ligios, F. Dusik, C. Capelle, H. Qin, H. Agis, R. Kain, C. Hengstenberg, R. Badr Eslam, D. Bonderman   +14 more
semanticscholar   +1 more source

Pericardial effusion under nivolumab: case-reports and review of the literature

Journal of Immunotherapy for Cancer, 2019
BackgroundNivolumab, a programmed death-1 (PD-1) inhibitor, is an immune checkpoint inhibitor particularly used in the treatment of malignant melanoma, non-small cell lung cancer and renal cell carcinoma.
Saade Anastasia, M. Audrey, A. Jennifer, Thibault Constance, Mirabel Mariana, G. François, O. Stéphane, W. Laurence   +7 more
semanticscholar   +1 more source

Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases

Frontiers in Oncology, 2019
Background: Nivolumab is an immune checkpoint inhibitor (ICI) that has shown efficacy for treating non-small cell lung cancer and has become a standard therapy for previously treated non-small cell lung cancer.
M. Yamasaki, Wakako Daido, Naomi Saito, K. Funaishi, Takenori Okada, Kazuma Kawamoto, Y. Matsumoto, N. Matsumoto, M. Taniwaki, N. Ohashi, N. Hattori   +10 more
semanticscholar   +1 more source